+467.0%
MRNA vs CRL
+80.5%
+386.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CRL | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +1.9% | +3.5% | +3.9% |
| 7D | -1.1% | -3.5% | +2.5% | +1.8% |
| 30D | +126.1% | -2.1% | +128.3% | +132.2% |
| 3M | +190.0% | +48.0% | +142.1% | +139.8% |
| 6M | +157.2% | +64.7% | +92.5% | +97.3% |
| YTD | +388.2% | +39.5% | +348.7% | +319.4% |
| 1Y | +467.0% | +74.2% | +392.8% | +314.3% |
| All | +467.0% | +80.5% | +386.5% | +314.3% |
Cumulative growth
Daily Returns
Daily percentage return beside CRL.
Daily Out/Under-Performance
Portfolio return minus CRL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CRL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CRL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling